JPMorgan Chase & Co’s Impel Pharmaceuticals Inc. Common Stock IMPL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-359
| Closed | -$154 | – | 6836 |
|
|
2023
Q3 | $154 | Hold |
359
| – | – | ﹤0.01% | 5911 |
|
|
2023
Q2 | $456 | Sell |
359
-2,700
| -88% | -$3.43K | ﹤0.01% | 5647 |
|
|
2023
Q1 | $4K | Buy |
3,059
+2,700
| +752% | +$3.53K | ﹤0.01% | 5457 |
|
|
2022
Q4 | $1K | Sell |
359
-962
| -73% | -$2.68K | ﹤0.01% | 5515 |
|
|
2022
Q3 | $6K | Buy |
1,321
+309
| +31% | +$1.4K | ﹤0.01% | 5170 |
|
|
2022
Q2 | $9K | Sell |
1,012
-4,703
| -82% | -$41.8K | ﹤0.01% | 5206 |
|
|
2022
Q1 | $36K | Buy |
5,715
+1,618
| +39% | +$10.2K | ﹤0.01% | 5120 |
|
|
2021
Q4 | $36K | Buy |
4,097
+1,635
| +66% | +$14.4K | ﹤0.01% | 5180 |
|
|
2021
Q3 | $30K | Sell |
2,462
-4,191
| -63% | -$51.1K | ﹤0.01% | 5070 |
|
|
2021
Q2 | $59K | Buy |
+6,653
| New | +$59K | ﹤0.01% | 4901 |
|